The study also demonstrated that stenoses can be diagnosed with the same high accuracy as with invasive x-ray angiography. At the University Hospital in Zürich in Switzerland, 120 patients with suspected coronary heart disease were scanned with the world's first CT scanner with two X-ray tubes; a Somatom Definition from Siemens Heathcare.
The Siemens application, Adaptive Cardio Sequence with the step-and-shoot mode, was also used for the first time with a dual-source CT. The results of the study were published in the June issue of "Heart", the official journal of the British Cardiovascular Society.*
Angiography is a diagnostic procedure used to clarify coronary arterial occlusion. Normally, this examination is conducted using angiography devices in the catheter laboratory and computed tomographs (CT); But with CT, the question of the radiation dosage plays a huge role. Researchers at the University Hospital in Zürich now want to see whether the dose used during CT angiography can be reduced. The research team examined 120 patients with suspected coronary heart disease in a Somatom Definition from Siemens, the world's first computed tomograph with two x-ray tubes.
The researchers used the new application "Adaptive Cardio Sequence", which was recently developed by Siemens for all Somatom Definition Scanners. The application is based on the step-and-shoot method, in which the next respective diastole is calculated and only this phase of the cardiac cycle is used to obtain image data. The combination of Adaptive Cardio Sequence and the DSCT's maximum time resolution of 83 msec facilitates this technique in a particularly reliable fashion and permits a further significant reduction in dosage.
"The results show that CT coronary angiography with a dual-source CT in step-and-shoot mode produces images of excellent diagnostic quality in patients with stable heart rates up to 70 bpm. The dosage reduction achieved in comparison to previous CT angiography is also remarkable. In our study, we required an effective dose of 2.5 mSv on average with a deviation of plus/minus 0.8 mSv. In the literature, a normal average effective dose for heart scans of between 9 and 21 mSv is reported," said Dr. Hatem Alkadhi, specialist in Radiology at the Institute for Diagnostic Radiology, University Hospital Zürich, Switzerland.
The Adaptive Cardio Sequence supplements the step-and-shoot method with intelligent algorithms, which monitor the heart frequency of patients and, if necessary, respond to arrhythmia, such as extrasystoles, additional heart beats. In this case, the recording phase is automatically postponed in order to avoid image errors due to the sudden movement. In addition, the recording window can be widened a little more if required so that, with the Adaptive Cardio Sequence, the robustness of the CT scan can be increased significantly overall.
"For Siemens, the safety of the patients has always been the primary focus of the developments in CT. At the same time, we consider our highest obligation to be to give doctors the best diagnostic image quality and to support them in making their workflow as efficient as possible. With this outlook and constant further development, Siemens has positioned itself as the market leader in CT technology," said Dr. Sami Atiya, CEO, Computed Tomography, Siemens Healthcare. "Innovations for dose reduction in conjunction with improved diagnostic image quality, are therefore of the utmost importance to us. This is why we have also further developed our Adaptive Cardio Sequence, now for the dual-source CT. The study from Zürich confirms to us that the combination of step-and-shoot and dual-source computed tomography does significantly reduce the dosage required during heart scans."
*H. Scheffel, MD, H. Alkadhi, MD, S. Leschka, MD, A. Plass, L. Desbiolles, I. Gruber et al: Low-Dose CT Coronary Angiography in the Step-and-Shoot Mode: Diagnostic Performance, in Heart online, 2 Jun 2008
Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Health and Medicine
20.04.2018 | Materials Sciences
20.04.2018 | Earth Sciences